To establish a dynamic nomogram based on preoperative clinical data for prediction of lateral lymph node metastasis (LLNM) of papillary thyroid carcinoma.
Study Design
Retrospective study.
Setting
The Sixth Affiliated Hospital of Sun Yat-Sen University.
Methods
The data of 477 patients from 2 centers formed the training group and validation group and were retrospectively reviewed. Preoperative clinical factors influencing LLNM were identified by univariable and multivariable analysis and were to construct a predictive dynamic nomogram for LLNM. Receiver operating characteristic analysis and calibration curves were used to evaluate the predictive power of the nomogram.
Results
The following were identified as independent risk factors for LLNM: male sex (odds ratio [OR] = 4.6, P = .04), tumor size ≥10.5 mm (OR = 7.9, P = .008), thyroid nodules (OR = 6.1, P = .013), irregular tumor shape (OR = 24.6, P = .001), rich lymph node vascularity (OR = 9.7, P = .004), and lymph node location. The dynamic nomogram constructed with these factors is available at https://zxh1119.shinyapps.io/DynNomapp/. The nomogram showed good performance, with an area under the curve of 0.956 (95% CI, 0.925-0.986), a sensitivity of 0.87, and a specificity of 0.91, if high-risk patients were defined as those with a predicted probability ≥0.3 or total score ≥200. The nomogram performed well in the external validation cohort (area under the curve, 0.915; 95% CI, 0.862-0.967).
Conclusions
The dynamic nomogram for preoperative prediction of LLNM in papillary thyroid carcinoma can help surgeons identify high-risk patients and develop individualized treatment plans.
La VecchiaCMalvezziMBosettiC, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136:2187-2195.
2.
ItoYMiyauchiAKiharaMFukushimaMHigashiyamaTMiyaA.Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J Surg. 2018;42:615-622.
3.
EskanderAMerdadMFreemanJLWitterickIJ.Pattern of spread to the lateral neck in metastatic well-differentiated thyroid cancer: a systematic review and meta-analysis. Thyroid. 2013;23:583-592.
4.
HuDZhouJHeW, et al. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World J Surg Oncol. 2018;16:30.
5.
LiuCXiaoCChenJ, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019;19:622.
6.
AdamMAPuraJGoffredoP, et al. Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol. 2015;33:2370-2375.
7.
GroganRHKaplanSPCaoH, et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery (Oxf). 2013;154:1436-1446.
8.
RohJLParkJYParkCI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007;245:604-610.
9.
MachadoMRTavaresMRBuchpiguelCAChammasMC.Ultrasonographic evaluation of cervical lymph nodes in thyroid cancer. Otolaryngol Head Neck Surg. 2017;156:263-271.
10.
WeiXWangMWangX, et al. Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site. Cancer Biol Med. 2019;16:587-594.
11.
GrassoMPuzzielloADe PalmaM.Preoperative ultrasound evaluation of laterocervical lymph nodes: timing and experience modify the treatment of patients with differentiated thyroid cancer. Updates Surg. 2019;71:711-715.
12.
PodnosYDSmithDWagmanLDEllenhornJD.The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731-734.
13.
WuMHShenWTGosnellJDuhQY.Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Head Neck. 2015;37:1336-1343.
14.
FengJWYangXHWuBQ, et al. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin Transl Oncol. 2019;21:1482-1491.
15.
ItoYMiyauchiA.Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg. 2007;31:905-915.
16.
SapuppoGPalermoFRussoM, et al. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. J Endocrinol Invest. 2017;40:1355-1363.
17.
ChungYSKimJYBaeJS, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid. 2009;19:241-246.
18.
WuXLiBZhengCHeX.Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma. Medicine (Abingdon). 2019;98:e16386.
19.
ItoYFukushimaMHigashiyamaT, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013;60:113-117.
20.
JinSBaoWYangYTBaiTBaiY.Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma. Sci Rep. 2018;8:17355.
21.
WangYGuanQXiangJ.Nomogram for predicting level V lymph node metastases in papillary thyroid carcinoma with clinically lateral lymph node metastases: a large retrospective cohort study of 1037 patients from FDUSCC. J Cancer. 2019;10:772-778.
22.
SoYKKimMJKimSSonYI.Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J Surg. 2018;50:94-103.
23.
NieXTanZGeMJiangLWangJZhengC.Risk factors analyses for lateral lymph node metastases in papillary thyroid carcinomas: a retrospective study of 356 patients. Arch Endocrinol Metab. 2016;60:492-499.
24.
JeonMJChungMSKwonH, et al. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis. Clin Endocrinol (Oxf). 2017;86:845-851.
25.
ItoYMiyauchiAKiharaMHigashiyamaTKobayashiKMiyaA.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27-34.
26.
FranssilaKOHarachHR.Occult papillary carcinoma of the thyroid in children and young adults: a systemic autopsy study in Finland. Cancer. 1986;58:715-719.
27.
KimMJLeeSGKimK, et al. Current trends in the features of male thyroid cancer: retrospective evaluation of their prognostic value. Medicine (Abingdon). 2019;98:e15559.
28.
GirardiFMBarraMBZettlerCG.Predictive factors for lymph node metastasis in solitary papillary thyroid carcinomas: a retrospective study. Pathol Oncol Res. 2015;21:59-64.
29.
RahbariRZhangLKebebewE.Thyroid cancer gender disparity. Future Oncol. 2010;6:1771-1779.
30.
ZahediABondazLRajaramanM, et al. Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation. Thyroid. 2020;30(6):871-877.
31.
ZaneMParelloCPennelliG, et al. Estrogen and thyroid cancer is a stem affair: a preliminary study. Biomed Pharmacother. 2017;85:399-411.
32.
SiddiquiSWhiteMGAnticT, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid. 2016;26:807-815.
33.
KimSKParkIHurN, et al. Patterns, predictive factors, and prognostic impact of contralateral lateral lymph node metastasis in N1b papillary thyroid carcinoma. Ann Surg Oncol. 2017;24:1943-1950.
34.
LeeKJChoYJKimSJ, et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg. 2011;35:318-323.
35.
FengJWQinACYeJPanHJiangYQuZ.Predictive factors for lateral lymph node metastasis and skip metastasis in papillary thyroid carcinoma. Endocr Pathol. 2020;31(1):67-76.
36.
LiuZSunMXiaoYYangJZhangTZhaoY.Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: a prospective study. Asian J Surg. 2017;40:270-277.
37.
SunWLanXZhangH, et al. Risk factors for central lymph node metastasis in cn0 papillary thyroid carcinoma: a systematic review and meta-analysis. PLoS One. 2015;10:e0139021.
38.
XuYXuLWangJ.Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Res. 2018;221:128-134.
39.
GongYYangJYanS, et al. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy. Medicine (Abingdon). 2018;97:e12263.
40.
ItoYTomodaCUrunoT, et al. Papillary microcarcinoma of the thyroid: how should it be treated. World J Surg. 2004;28:1115-1121.
41.
FoschiniMPPapottiMParmeggianiA, et al. Three-dimensional reconstruction of vessel distribution in benign and malignant lesions of thyroid. Virchows Arch. 2004;445:189-198.
42.
ZhaoWChenSHouXLiaoQChenGZhaoY.Predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma. Pathol Oncol Res. 2019;25:1245-1251.
43.
FuAZCantorSBKattanMW.Use of nomograms for personalized decision-analytic recommendations. Med Decis Making. 2010;30:267-274.
44.
GrimesDA.The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008;149:273-275.
